Patents by Inventor Ernestt Kun

Ernestt Kun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6303629
    Abstract: The present invention is directed to a method for treating inflammation or inflammatory disease, bacterial infection, arthritis and stroke in an animal or mammal, which comprises the steps of administering an effective amount of a pADPRT inhibitory compound to said animal or mammal.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: October 16, 2001
    Assignee: Octamer, Inc.
    Inventor: Ernestt Kun
  • Patent number: 5922775
    Abstract: The present invention provides methods for treating cancer, particularly malignant tumors, with ketone thyroxine analogues having no significant hormonal activity. A ketone thyroxine analogue is administered to an afflicted mammal in an amount effective to cause depression or regression of malignant tumor growth or to treat cancer. Particularly preferred ketone thyroxine analogues are those capable of causing about 35 percent or more inhibition of initial velocity of microtubule protein assembly in vitro.
    Type: Grant
    Filed: October 23, 1997
    Date of Patent: July 13, 1999
    Assignee: Octamer, Inc.
    Inventors: Ernestt Kun, Jerome Mendeleyev, Kalman G. Buki
  • Patent number: 5908861
    Abstract: The present invention is directed to a method for treating inflammation or inflammatory disease in an animal or mammal, which comprises the steps of administering an effective amount of an pADPRT inhibitory compound to said animal or mammal.
    Type: Grant
    Filed: May 13, 1997
    Date of Patent: June 1, 1999
    Assignee: Octamer, Inc.
    Inventor: Ernestt Kun